Diagenode

The Inhibition of the Histone Methyltransferase EZH2 by DZNEP or SiRNA Demonstrates Its Involvement in MGMT, TRA2A, RPS6KA2, and U2AF1 Gene Regulation in Prostate Cancer.


El Ouardi D, Idrissou M, Sanchez A, Penault-Llorca F, Bignon YJ, Guy L, Bernard-Gallon D

In France, prostate cancer is the most common cancer in men (Bray et al., 2018). Previously, our team has reported the involvement of epigenetic factors in prostate cancer (Ngollo et al., 2014, 2017). The histone 3 lysine 27 trimethylation (H3K27me3) is a repressive mark that induces chromatin compaction and thus gene inactivation. This mark is regulated positively by the methyltransferase EZH2 that found to be overexpressed in prostate cancer.

Tags
Antibody

Share this article

Published
December, 2019

Source

Products used in this publication

  • ChIP-seq Grade
    C15410039-50
    EZH2 Antibody - ChIP-seq Grade
  • cut and tag antibody icon
    C15410195
    H3K27me3 Antibody - ChIP-seq Grade
  • Mouse IgG
    C15410206
    Rabbit IgG

活动

  • EpiNantes 2024
    Nantes, France
    Sep 24-Sep 25, 2024
  • Nanopore Research Day Antwerp
    Antwerp, Belgium
    Sep 27, 2024
  • 10th Canadian Conference on Epigenetics
    Ontario, Canada
    Oct 1-Oct 4, 2024
 查看所有活动

 


       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy